Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

Published:2020-05-06 Issue:13 Volume:9 Page:4622-4631
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shaverdian Narek¹^ORCID,Thor Maria²,Shepherd Annemarie F.¹,Offin Michael D.³^ORCID,Jackson Andrew²,Wu Abraham J.¹,Gelblum Daphna Y.¹,Yorke Ellen D.²,Simone Charles B.¹^ORCID,Chaft Jamie E.³,Hellmann Matthew D.³,Gomez Daniel R.¹,Rimner Andreas¹,Deasy Joseph O.²

Affiliation:

1. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA

2. Department of Medical Physics Memorial Sloan Kettering Cancer Center New York New York USA

3. Thoracic Oncology Service Division of Solid Tumor Oncology Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

Funder

NIH/NCI

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3113

Reference33 articles.

1. Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

2. Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

3. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

4. Non-Small Cell Lung Cancer Therapy-Related Pulmonary Toxicity: An Update on Radiation Pneumonitis and Fibrosis

5. Radiation Pulmonary Toxicity: From Mechanisms to Management

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritizing Patient-Centered Care in a World of Increasingly Advanced Technologies and Disconnected Care;Seminars in Radiation Oncology;2024-10

2. Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis;Radiotherapy and Oncology;2024-07

3. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

4. Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation;European Journal of Cancer Care;2024-04-27

5. Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer;Cancers;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3